Abstract

Iowa Oncology Research Association's intent is to continue to bring the advantages of treatment with clinical research programs to the cancer patients of central Iowa during the next three years of CCOP. Through our affiliation with North Central Cancer Treatment Group, Eastern Cooperative Oncology Group and Children's Cancer Study Group we hope to contribute to the reduction of cancer mortality in our region by speeding transfer of newly developed cancer treatment technology to widespread community application. With our expanding membership of practicing physicians and excellent working relationship with the hospitals in our CCOP consortium, we will be able to involve a wider segment to investigate the impact of cancer therapy. We plan to increase our participation in present cancer control studies as well as develop future research programs for our community. The Principal Investigator of Iowa Oncology Research Association is an appointed representative of both North Central Cancer Treatment Group and Eastern Cooperative Oncology Group cancer control committees; therefore, Iowa Oncology Research Association CCOP will be instrumental in developing additional programs for use in central Iowa. Our recently acquired cancer control program, HemoQuant Detection of Colorectal Neoplasia (North Central Cancer Treatment Group study 84-46-51) has generated positive patient response and cooperation from our community physicians. It is our intent to enter at least 75 patients in the next twelve months on clinical cancer research protocols and 125 patients on cancer control programs. By virtue of our established programs and those programs under active development we can confidently predict we will easily meet our objectives

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
2U10CA035101-04
Application #
3557479
Study Section
(SRC)
Project Start
1983-09-15
Project End
1990-05-31
Budget Start
1987-06-15
Budget End
1988-05-31
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost

  Institution

Name
Iowa Oncology Research Association
Department
Type
DUNS #
180870891
City
Des Moines
State
IA
Country
United States
Zip Code
50309

  Publications

Barton, Debra L; Sloan, Jeff A; Shuster, Lynne T et al. (2018) Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer 26:643-650
Schild, Steven E; Hillman, Shauna L; Tan, Angelina D et al. (2017) Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance). J Thorac Oncol 12:697-703
Liu, Xiaonan; Li, Jing; Schild, Steven E et al. (2017) Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy. J Cancer Ther 8:73-85
Sio, Terence T; Atherton, Pamela J; Birckhead, Brandon J et al. (2016) Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]). Support Care Cancer 24:3847-55
Liu, Xiaonan; Li, Jing; Wu, Teresa et al. (2016) Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ? 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers. OMICS J Radiol 5:
Pachman, Deirdre R; Qin, Rui; Seisler, Drew et al. (2016) Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505). Support Care Cancer 24:5059-5068
Rule, William G; Foster, Nathan R; Meyers, Jeffrey P et al. (2015) Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis. J Geriatr Oncol 6:119-26
Park, Haeseong; Qin, Rui; Smith, Thomas J et al. (2015) North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause 22:627-32
Van Loon, Katherine; Espinoza, Anne M; Fogelman, David R et al. (2014) Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab. Pancreas 43:343-9
Dronca, Roxana S; Allred, Jacob B; Perez, Domingo G et al. (2014) Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675. Am J Clin Oncol 37:369-76

Showing the most recent 10 out of 161 publications